Eli Lilly Corp. buy gerihouse
Summary
This prediction ended on 08.08.16 with a price of €72.78. The BUY prediction by gerihouse finished with a performance of 16.05%. gerihouse has a follow-up prediction for Eli Lilly Corp. where he still thinks Eli Lilly Corp. is a Buy. gerihouse has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Eli Lilly Corp. | -3.513% | -3.513% | 92.507% | 333.280% |
| iShares Core DAX® | 1.051% | -1.833% | 12.822% | 15.392% |
| iShares Nasdaq 100 | -0.547% | -3.738% | 40.625% | 42.396% |
| iShares Nikkei 225® | -1.778% | -8.115% | 16.092% | 0.891% |
| iShares S&P 500 | 0.002% | -2.226% | 28.387% | 41.095% |
According to gerihouse what are the pros and cons of Eli Lilly Corp. for the foreseeable future?
Pros
Cons
Comments by gerihouse for this prediction
In the thread Eli Lilly Corp. diskutieren
Sicher
Ich liebe diese Aktie!
BMO Capital Markets reaffirmed their outperform rating on shares of Eli Lilly and Co (NYSE:LLY) in a research report released on Wednesday morning, Analyst Ratings.Net reports. They currently have a $95.00 price objective on the stock.
A number of other equities research analysts have also issued reports on the company. Vetr upgraded Eli Lilly and from a buy rating to a strong-buy rating and set a $88.69 target price for the company in a research note on Thursday, January 28th. Barclays upgraded Eli Lilly and from an equal weight rating to an overweight rating and increased their target price for the company from $75.00 to $95.00 in a research note on Tuesday, December 1st. Jefferies Group reiterated a buy rating and issued a $125.00 target price on shares of Eli Lilly and in a research note on Monday, January 4th. Bank of America reiterated a buy rating and issued a $108.00 target price (up previously from $104.00) on shares of Eli Lilly and in a research note on Tuesday, December 22nd. Finally, Atlantic Securities started coverage on Eli Lilly and in a research note on Friday, December 18th. They issued an overweight rating and a $100.00 target price for the company. Four equities research analysts have rated the stock with a hold rating and seventeen have assigned a buy rating to the company’s stock. Eli Lilly and has a consensus rating of Buy and an average target price of $96.55.
Current prediction by gerihouse for Eli Lilly Corp.
Eli Lilly Corp.
16.11.23
16.11.24
13:17
Stopped prediction by gerihouse for Eli Lilly Corp.
Eli Lilly Corp.
04.11.22
04.11.23
05.11.23
Eli Lilly Corp.
18.01.22
18.01.23
23.09.22
Eli Lilly Corp.
25.01.21
25.01.22
17.01.22
Eli Lilly Corp.
18.03.20
12.10.20
12.10.20
Eli Lilly Corp.
13.10.19
26.10.19
26.10.19
Eli Lilly Corp.
06.09.19
13.10.19
13.10.19
Eli Lilly Corp.
24.06.19
06.09.19
06.09.19
Eli Lilly Corp.
18.04.19
24.05.19
24.05.19
Eli Lilly Corp.
24.01.19
04.04.19
04.04.19
Eli Lilly Corp.
10.05.18
06.09.18
06.09.18
Eli Lilly Corp.
31.08.17
10.11.17
10.11.17
Eli Lilly Corp.
10.11.16
18.04.17
18.04.17
Eli Lilly Corp.
13.10.15
04.01.16
04.01.16
Eli Lilly Corp.
05.05.15
22.07.15
22.07.15
Eli Lilly Corp.
11.09.14
24.11.14
24.11.14
Eli Lilly Corp.
09.10.12
21.02.13
21.02.13
Eli Lilly Corp.
04.07.12
05.09.12
05.09.12